ECMC Announcement – National Lung Matrix Trial update

The National Lung Matrix Trial (NLMT) is a flagship trial in the UK, being the first to combine the development of a technology platform that screens for multiple genetic aberrations in tumours (provided by CRUK's Stratified Medicine Programme 2) with testing of multiple novel genetic-marker-directed drugs.